| __timestamp | Dr. Reddy's Laboratories Limited | Vericel Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 38783000000 | 13774000 |
| Thursday, January 1, 2015 | 42585000000 | 22479000 |
| Friday, January 1, 2016 | 45702000000 | 27388000 |
| Sunday, January 1, 2017 | 46372000000 | 35610000 |
| Monday, January 1, 2018 | 46910000000 | 49007000 |
| Tuesday, January 1, 2019 | 48890000000 | 61139000 |
| Wednesday, January 1, 2020 | 50129000000 | 68836000 |
| Friday, January 1, 2021 | 54559000000 | 97592000 |
| Saturday, January 1, 2022 | 62081000000 | 106903000 |
| Sunday, January 1, 2023 | 105931000000 | 120998000 |
| Monday, January 1, 2024 | 77201000000 |
Igniting the spark of knowledge
In the ever-evolving pharmaceutical and biotechnology sectors, understanding spending patterns is crucial. Dr. Reddy's Laboratories Limited, a major player in the pharmaceutical industry, has shown a remarkable increase in its Selling, General, and Administrative (SG&A) expenses over the past decade. From 2014 to 2023, their SG&A expenses surged by approximately 173%, peaking in 2023. This growth reflects their aggressive expansion and strategic investments.
On the other hand, Vericel Corporation, a biotechnology firm, has also seen a steady rise in SG&A expenses, growing nearly ninefold from 2014 to 2023. This increase underscores their commitment to innovation and market penetration. However, data for 2024 is missing, leaving room for speculation on future trends.
These contrasting spending patterns highlight the diverse strategies employed by companies in the healthcare sector, offering valuable insights for investors and industry analysts.
Regeneron Pharmaceuticals, Inc. and Vericel Corporation: SG&A Spending Patterns Compared
Operational Costs Compared: SG&A Analysis of GSK plc and Vericel Corporation
Comparing SG&A Expenses: Biogen Inc. vs Dr. Reddy's Laboratories Limited Trends and Insights
United Therapeutics Corporation vs Vericel Corporation: SG&A Expense Trends
Breaking Down SG&A Expenses: Dr. Reddy's Laboratories Limited vs Jazz Pharmaceuticals plc
Cost Management Insights: SG&A Expenses for Dr. Reddy's Laboratories Limited and Xenon Pharmaceuticals Inc.
SG&A Efficiency Analysis: Comparing Dr. Reddy's Laboratories Limited and Iovance Biotherapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Dr. Reddy's Laboratories Limited and Taro Pharmaceutical Industries Ltd.
Cost Management Insights: SG&A Expenses for Bio-Techne Corporation and Vericel Corporation
Who Optimizes SG&A Costs Better? Alkermes plc or Vericel Corporation
SG&A Efficiency Analysis: Comparing Perrigo Company plc and Vericel Corporation
Comparing SG&A Expenses: Vericel Corporation vs MiMedx Group, Inc. Trends and Insights